Company / R&D per Share
ANI Pharmaceuticals, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.45
FY2025
5-year range
$0.90 / $2.74
FY2021-FY2025
Trend
-10.7%
vs FY2024
Sector context
#86 of 208
Health Care
What the data says
At $2.45, ANI Pharmaceuticals, Inc.'s r&d per share ranks #86 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $0.25 in FY2016 to $2.74 in FY2024.
Based on SEC 10-K filings.
2.45 in FY2025 with a 5-year CAGR of +12.8%.
Improved from $1.88 to $2.45 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +21.3%
- 5-Year CAGR
- +12.8%
- 10-Year CAGR
- -
Sector benchmark
#86 of 208 in Health CareTop 41% of 208This company $2.45 Sector average $28.82
▼
-91.5% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 10.7% year-over-year.
- Ranks #86 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.45 | -10.7% |
| FY2024 | $2.74 | +45.5% |
| FY2023 | $1.88 | +37.3% |
| FY2022 | $1.37 | +52.1% |
| FY2021 | $0.90 | -32.5% |
| FY2020 | $1.34 | -22.0% |
| FY2019 | $1.72 | +31.2% |
| FY2018 | $1.31 | +66.6% |
| FY2017 | $0.78 | +212.5% |
| FY2016 | $0.25 | -99.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026